Results 51 to 60 of about 9,321,576 (296)

Cdk1: Unsung Hero of S Phase? [PDF]

open access: yesCell Cycle, 2004
Cdk2 has been viewed as a key cell cycle regulator that is essential for S phase progression. The recent discovery that Cdk2 is not required for cell proliferation in mice now shows that other factors must be able to replace Cdk2 in stimulating DNA replication.
Marcin, Pacek   +2 more
openaire   +2 more sources

Dexamethasone for Chemotherapy‐Induced Nausea and Vomiting Prevention in Pediatric Patients: International Consensus

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Background An international Delphi panel of experts developed consensus statements to delineate the circumstances where the risks of dexamethasone as an antiemetic do and do not outweigh its benefits. Procedure Experts in supportive care of pediatric patients were invited to participate.
Negar Shavandi   +20 more
wiley   +1 more source

Cell size at S phase initiation: an emergent property of the G1/S network. [PDF]

open access: yesPLoS Computational Biology, 2007
The eukaryotic cell cycle is the repeated sequence of events that enable the division of a cell into two daughter cells. It is divided into four phases: G1, S, G2, and M.
Matteo Barberis   +3 more
doaj   +1 more source

Quantum effective potential for U(1) fields on S^2_L X S^2_L

open access: yes, 2005
We compute the one-loop effective potential for noncommutative U(1) gauge fields on S^2_L X S^2_L. We show the existence of a novel phase transition in the model from the 4-dimensional space S^2_L X S^2_L to a matrix phase where the spheres collapse ...
A. Connes   +22 more
core   +1 more source

Spin Reduction Transition in Spin-3/2 Random Heisenberg Chains [PDF]

open access: yes, 2002
Random spin-3/2 antiferromagnetic Heisenberg chains are investigated using an asymptotically exact renormalization group. Randomness is found to induce a quantum phase transition between two random-singlet phases.
A.H. Castro Neto   +23 more
core   +2 more sources

Clinical Insights Into Hypercalcemia of Malignancy in Childhood

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Hypercalcemia of malignancy (HCM) is a rare but life‐threatening metabolic emergency in children that occurs in less than 1% of pediatric cancer cases, with a reported incidence ranging from 0.4% to 1.0% across different studies. While it is observed in 10%–20% of adult malignancies, pediatric HCM remains relatively uncommon.
Hüseyin Anıl Korkmaz
wiley   +1 more source

S-phase-independent silencing establishment in Saccharomyces cerevisiae

open access: yeseLife, 2020
The establishment of silent chromatin, a heterochromatin-like structure at HML and HMR in Saccharomyces cerevisiae, depends on progression through S phase of the cell cycle, but the molecular nature of this requirement has remained elusive despite ...
Davis Goodnight, Jasper Rine
doaj   +1 more source

Regulation in S Phase by E2F [PDF]

open access: yesCell Cycle, 2004
The DNA synthetic S phase of the unperturbed cell cycle is a closed system, as compared to regulation of G(1) by external growth factors. The E2F family provides internal control in S phase by transcribing genes required for deoxynucleotide triphosphate (dNTP) and DNA synthesis.
Arthur B, Pardee   +2 more
openaire   +2 more sources

Survival Outcomes and Complications Among Canadian Children With Retinoblastoma: A Population‐Based Report From CYP‐C

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Purpose Retinoblastoma (RB) is the most common pediatric ocular cancer, yet population‐based data on survival and risk factors remain limited. This study aimed to describe survival in a large national RB cohort and identify predictors of death and complications.
Samuel Sassine   +14 more
wiley   +1 more source

Integrated single-cell transcriptome and TCR profiles of hepatocellular carcinoma highlight the convergence on interferon signaling during immunotherapy

open access: yesJournal for ImmunoTherapy of Cancer
Background Despite the success of immune checkpoint inhibitor (ICI)-based combination therapies in hepatocellular carcinoma (HCC), its effectiveness remains confined to a subset of patients.
Xiaobo Li   +13 more
doaj   +1 more source

Home - About - Disclaimer - Privacy